Navigation Links
Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials
Date:9/16/2013

NEW YORK, Sept. 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials

http://www.reportlinker.com/p01623958/Global-Markets-for-Emerging-Insulin-Drug-and-Delivery-Technologies---Focus-on-Syringes-and-Vials.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

REPORT HIGHLIGHTS This report provides:

An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin syringes and vials.

Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.

Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.

Patent identifications for insulin as a drug, along with its delivery methods.

STUDY OBJECTIVES BCC Research's objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices.This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market's improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018.Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.REASONS FOR DOING THIS STUDY The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.Companies' acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.CONTRIBUTIONS OF THE STUDY AND FOR WHOM This study contributes to the areas of market growth for insulin drug and delivery manufacturers and users. It will be of interest to pharmaceutical biotechnical companies, research institutes, hospitals and physicians.SCOPE OF THE STUDY The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.METHODOLOGY Both primary and secondary research methodologies were used in the preparation of this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.INFORMATION SOURCES Many companies were surveyed to obtain data for this study. including manufacturers of insulin drugs and delivery technologies and their users in hospitals and medical centers. Data were gathered from various industry sources. BCC Research spoke with officials within the industry and also consulted newsletters; company literature; product literature; and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

CHAPTER 1 INTRODUCTION 2

STUDY OBJECTIVES 2

REASONS FOR DOING THIS STUDY 2

CONTRIBUTIONS OF THE STUDY AND FOR WHOM 2

SCOPE OF THE STUDY 3

METHODOLOGY 3

INFORMATION SOURCES 3

ABOUT THE AUTHOR 3

RELATED BCC RESEARCH REPORTS 4

BCC ONLINE SERVICES 4

DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,

THROUGH 2018 ($ MILLIONS) 7

SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,

2011-2018 ($ MILLIONS) 8

CHAPTER 3 OVERVIEW 10

DIABETES OVERVIEW 10

DIABETES CLASSIFICATION 10

TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11

EPIDEMIOLOGY 13

TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH

RESPECT TO 2000 13

TYPE 1 DIABETES MELLITUS MANAGEMENT 14

INSULIN 15

HISTORY OF INSULIN ISOLATION AND THE DEVELOPMENT OF ITS ANALOGS 15

TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15

STRUCTURE OF INSULIN 16

INSULIN BIOSYNTHESIS 16

INSULIN TYPES 17

TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19

TREATMENT PROTOCOL 20

Multiple Daily Injections 20

TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21

Continuous Subcutaneous Insulin Infusion and Insulin Pump Therapy 21

TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22

TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR

VARIOUS INSULIN DELIVERY SYSTEMS 23

TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25

ADMINISTRATION ROUTES 26

TABLE 9 INSULIN ADMINISTRATION ROUTES 27

CHAPTER 4 REGULATORY ASPECTS 29

APPROVALS FOR INSULIN DRUGS 29

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29

APPROVALS GRANTED FOR INSULIN DEVICES 30

TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN

DEVICES, 2009–MARCH 2013 30

PREMARKET NOTIFICATION OR 510(K) CLEARANCE 32

TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN

DEVICES, 2009–MARCH 2013 33

SAFETY ALERTS AND RECALLS 34

TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 34

TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 35

CHAPTER 5 NEW DEVELOPMENTS 41

NEW TECHNOLOGIES FOR INSULIN DELIVERY 42

INSULIN INHALERS 42

INSULIN SPRAY 42

IMPLANTABLE INSULIN PUMPS 42

TRANSDERMAL PATCH 42

PRODUCT DEVELOPMENT 43

TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43

MERGERS AND ACQUISITIONS 45

TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND

ACQUISITIONS 46

LICENSING, PARTNERSHIPS, AND AGREEMENTS 47

TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS

AND DELIVERY DEVICES 48

PIPELINE PRODUCTS 51

TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51

CHAPTER 6 GLOBAL MARKETS 56

MARKET BY TYPE 57

MARKET OVERVIEW 57

MARKET REVENUE 58

TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,

THROUGH 2018 ($ MILLIONS) 58

FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,

2011-2018 ($ MILLIONS) 59

MARKET SHARE 59

TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012

(%) 59

FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60

MARKET BY REGION 60

MARKET OVERVIEW 61

MARKET REVENUE 62

TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,

THROUGH 2018 ($ MILLIONS) 62

FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,

2011-2018 ($ MILLIONS) 63

MARKET SHARE 63

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012

(%) 63

FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63

INSULIN SYRINGES AND VIALS 64

Market Overview 64

Market Revenue 64

TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 65

FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($

MILLIONS) 65

Market Share 65

TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66

FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66

INSULIN PENS 66

Market Overview 67

Market Revenue 67

TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68

FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68

Market Share 68

TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69

FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69

INSULIN PUMPS 69

Market Overview 70

Market Revenue 71

TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 71

FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 72

Market Share 72

TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72

FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72

MARKET BY APPLICATIONS 73

TYPE 1 DIABETES 73

TYPE 2 DIABETES 74

GESTATIONAL DIABETES 75

MARKET OVERVIEW 75

MARKET REVENUE 76

TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,

THROUGH 2018 ($ MILLIONS) 76

FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY

APPLICATION, 2011-2018 ($ MILLIONS) 76

MARKET SHARE 77

TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,

2012 (%) 77

FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY

APPLICATION, 2012 (%) 77

CHAPTER 7 INSULIN SYRINGE AND VIAL MARKET ANALYSIS 80

MARKET BY TYPE 80

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

U-100 INSULIN SYRINGE 81

U-40 INSULIN SYRINGES 81

MARKET OVERVIEW 81

MARKET REVENUE FOR INSULIN SYRINGES 82

TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($

MILLIONS) 82

FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011-2018 ($ MILLIONS) 82

INSULIN SYRINGE MARKET SHARE 83

TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83

FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83

INSULIN SYRINGE AND VIAL MARKET REVENUE 84

TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($

MILLIONS) 84

FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011-2018 ($ MILLIONS) 84

INSULIN SYRINGE AND VIAL MARKET SHARES 85

TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85

FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85

MARKET BY REGION 86

MARKET OVERVIEW 86

INSULIN SYRINGE MARKET REVENUE 86

TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 87

FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 87

U-100 Insulin Syringe Market Revenue 87

TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 88

FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($

MILLIONS) 88

U-40 Insulin Syringe Market Revenue 88

TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 89

FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($

MILLIONS) 89

INSULIN SYRINGE AND VIAL MARKET REVENUE 90

TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 90

FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 91

INSULIN SYRINGE MARKET SHARES 91

TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91

FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91

INSULIN SYRINGE AND VIAL MARKET SHARES 92

TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92

FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92

MARKET BY APPLICATION 93

TYPE 1 DIABETES 93

TYPE 2 DIABETES 94

GESTATIONAL DIABETES 94

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

MARKET OVERVIEW 94

MARKET REVENUE FOR SYRINGES 95

TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95

FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS) 96

SYRINGE MARKET SHARES 96

TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96

FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96

SYRINGE AND VIAL MARKET REVENUE 97

TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($

MILLIONS) 98

FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011-2018 ($

MILLIONS) 98

SYRINGE AND VIAL MARKET SHARES 98

TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99

FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99

INDUSTRY STRUCTURE 99

MARKET LEADERS 100

TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND

VIALS 100

INSULIN SYRINGE MARKET SHARES 101

TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101

FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101

INSULIN SYRINGE AND VIAL MARKET SHARES 102

TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102

FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103

CHAPTER 8 PATENT ANALYSIS 105

PATENTS BY YEAR 105

TABLE 48 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 105

FIGURE 29 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105

PATENTS BY TYPE 106

TABLE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106

FIGURE 30 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106

PATENTS BY COMPANY 107

TABLE 50 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 107

PATENTS BY COUNTRY 109

TABLE 51 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109

FIGURE 31 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 110

PATENTS BY ASSIGNEE 110

TABLE 52 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110

FIGURE 32 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110

CHAPTER 9 CURRENT SITUATION 113

MARKET TRENDS 114

INSULIN PUMPS 114

Artificial Pancreas 114

Closed-Loop Insulin Pump 114

INSULIN PENS 115

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

INSULIN SYRINGES 115

MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS 115

ORAL INSULIN 115

NASAL INSULIN SPRAY 116

BIOSIMILAR INSULIN 116

OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET 116

FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET 117

COLLABORATIONS, MERGERS AND AQUISITIONS 117

CHAPTER 10 COMPANY PROFILES 121

ADOCIA 121

ANIMAS CORPORATION 121

ANTRIABIO 122

BECTON, DICKINSON AND COMPANY 123

BIOCON LIMITED 123

BIODEL INC. 124

DEBIOTECH 125

ELI LILLY 125

ETERNITY HEALTHCARE 126

F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG) 127

GENEREX BIOTECHNOLOGY CORPORATION 127

HALOZYME THERAPEUTICS INC. 128

INSULINE MEDICAL 128

INSULUTION ABM 129

LIFESCAN 129

MANNKIND 130

MARINA BIOTECH INC. 131

MEDTRONIC INC. 132

MICROPORT SCIENTIFIC CORPORATION 132

MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL

RX) 133

NOVO NORDISK 133

ORAMED PHARMACEUTICALS INC. 134

PHOSPHAGENICS LIMITED 135

SANOFI 135

SENSILE MEDICAL AG 136

THERMALIN DIABETES INC. 137

XERIS PHARMACEUTICALS 138

YPSOMED HOLDING AG 138

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

LIST OF TABLES SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,

THROUGH 2018 ($ MILLIONS) 7

TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11

TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH

RESPECT TO 2000 13

TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15

TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19

TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21

TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22

TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR

VARIOUS INSULIN DELIVERY SYSTEMS 23

TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25

TABLE 9 INSULIN ADMINISTRATION ROUTES 27

TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29

TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN

DEVICES, 2009–MARCH 2013 30

TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN

DEVICES, 2009–MARCH 2013 33

TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 34

TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013 35

TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43

TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND

ACQUISITIONS 46

TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND

DELIVERY DEVICES 48

TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51

TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,

THROUGH 2018 ($ MILLIONS) 58

TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%) 59

TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,

THROUGH 2018 ($ MILLIONS) 62

TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012

(%) 63

TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018

($ MILLIONS) 65

TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66

TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68

TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69

TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 71

TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72

TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,

THROUGH 2018 ($ MILLIONS) 76

TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,

2012 (%) 77

TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 82

TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83

TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($

MILLIONS) 84

TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 87

TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 88

TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 89

TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018

($ MILLIONS) 90

TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91

TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92

TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95

TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96

TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($

MILLIONS) 98

TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99

TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND

VIALS 100

TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101

TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102

TABLE 48 U.S. PATENTS, JANUARY 2009–MARCH 2013 (%) 105

TABLE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106

TABLE 50 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 107

TABLE 51 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109

TABLE 52 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110

HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes

and Vials

LIST OF FIGURES SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,

2011-2018 ($ MILLIONS) 8

FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,

2011-2018 ($ MILLIONS) 59

FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60

FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,

2011-2018 ($ MILLIONS) 63

FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63

FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($

MILLIONS) 65

FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66

FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68

FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69

FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 72

FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72

FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,

2011-2018 ($ MILLIONS) 76

FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,

2012 (%) 77

FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011-2018 ($ MILLIONS) 82

FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83

FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011-2018 ($ MILLIONS) 84

FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85

FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($

MILLIONS) 87

FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($

MILLIONS) 88

FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($

MILLIONS) 89

FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH

2018 ($ MILLIONS) 91

FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91

FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92

FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS) 96

FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96

FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011-2018 ($

MILLIONS) 98

FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99

FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101

FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103

FIGURE 29 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105

FIGURE 30 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106

FIGURE 31 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 110

FIGURE 32 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110

To order this report: Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vialshttp://www.reportlinker.com/p01623958/Global-Markets-for-Emerging-Insulin-Drug-and-Delivery-Technologies---Focus-on-Syringes-and-Vials.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 2016 The global  gamma ... billion by 2022, according to a new report ... towards a healthy lifestyle is expected to drive ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... health treatment expenditure has urged consumers to switch ...
(Date:4/26/2016)... FLINT, Mich. , April 26, 2016 ... the promotion of Jennifer Hagerman , Pharm D., ... In her growing role at Diplomat, Hagerman will continue ... of the company that delivers custom education and training ... to the specialty pharmacy industry. Diplomat University also houses ...
(Date:4/26/2016)... 26, 2016 US demand for infection ... 4.9 percent annually to $27.6 billion in 2020.  ... to decrease rates of healthcare-associated infections (HAIs) will ... and services.  Although declining, the overall rate of ... levels set by the CDC.  Recent statistics indicate ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to ... and podcasted thereafter . Dr. Bernie Siegel, author of a plethora of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... reveals that infants born with severe congenital diaphragmatic hernia have better survival rates ... with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent Marketing , ... exercise invention which aids in proper muscle development. , "The Gym & Exercise ... Director of World Patent Marketing. "Globalization has threatened the future growth of the ...
(Date:4/29/2016)... ... ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is an ... obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients who ... both jaw bones. This surgery is performed to correct the alignment of the jaw. It ...
(Date:4/29/2016)... ... 29, 2016 , ... Innovations with Ed Begley Jr., announced ... airing third quarter 2016 via Discovery Channel. Dates and show times TBA. , ... located in Greenwood, Wisconsin applies product research and development and continuous technological improvements ...
Breaking Medicine News(10 mins):